Paul E. Aldrich

1.8k citations

29 papers · 1.2k indexed · 1 hit paper · h-index 16

Virology top 5%
- HIV Research and Treatment 6
Organic Chemistry top 5%
- Chemical synthesis and alkaloids 4
Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 7
- HIV/AIDS Research and Interventions 3
Behavioral Neuroscience top 10%
Biochemistry top 10%
Ecology, Evolution, Behavior and Systematics
- Botanical Research and Chemistry 3
Analytical Chemistry
- Analytical Methods in Pharmaceuticals 3
Clinical Psychology
- Obsessive-Compulsive Spectrum Disorders 2
Molecular Biology
- Chemical Synthesis and Analysis 2

Co-authors: Andrew T. Chiu Michael E. Pierce William A. Price Joseph B. Santella David J. Carini A.L. Johnson John V. Duncia Gregory J. Wells
Cited by: Virology Organic Chemistry Infectious Diseases
Journals: Journal of the American Chemical Society (11 papers)Journal of Medicinal Chemistry (4 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
Partner nations: United States Australia United Kingdom

In The Last Decade

Paul E. Aldrich

28 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Paul E. Aldrich

Since Specialization

Citations

This map shows the geographic impact of Paul E. Aldrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Aldrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Aldrich more than expected).

Fields of papers citing papers by Paul E. Aldrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Aldrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Aldrich. The network helps show where Paul E. Aldrich may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul E. Aldrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul E. Aldrich Line = papers co-authored together Paul E. Aldrich links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Situational, emotional, and individual dispositions to weight gain in people with hoarding problems British Journal of Clinical Psychology ·Melissa M. Norberg,Richard J. Stevenson,Gary Wong,Mitchell Wayne,Paul E. Aldrich,Susanne Meares,STEPHEN G. STENING	2023	0
2	Attention, response inhibition, and hoarding: A neuropsychological examination Journal of Behavioral Addictions ·Melissa M. Norberg,Susanne Meares,Richard J. Stevenson,Mitchell Wayne,Gary Wong,Paul E. Aldrich,Jake Olivier	2023	3
3	Determination of Structure of β,δ-Dihydroxy-β-methylvaleric Acid Nutrition Reviews ·Donald E. Wolf,Carl H. Hoffman,Paul E. Aldrich,Helen R. Skeggs,Lemuel D. Wright,Karl Folkers	2009	1
4	Corticotropin-Releasing Hormone Receptor Antagonists: Framework Design and Synthesis Guided by Ligand Conformational Studies Journal of Medicinal Chemistry ·C. Nicholas Hodge,Paul E. Aldrich,Zelda R. Wasserman,Cấnh Toàn Nguyễn,Gregory A. Nemeth,Argyrios G. Arvanitis,Joan B. Speden Nzimlt,Robert J. Chorvat,Engelbert Ciganek,Thomas E. Christos,Paul J. Gilligan,Paul Krenitsky,Amanda Sehlgård,Kimberly Aderhold	1999	60
5	Design, Synthesis, and Evaluation of Tetrahydropyrimidinones as an Example of a General Approach to Nonpeptide HIV Protease Inhibitors Journal of Medicinal Chemistry ·George V. De Lucca,Jing Liang,Paul E. Aldrich,J. C. CALABRESE,Beverly C. Cordova,Ronald M. Klabe,Marlene M. Rayner,Chong‐Hwan Chang	1997	40
6	DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein Antimicrobial Agents and Chemotherapy ·Marlene M. Rayner,Beverly C. Cordova,M. J. Gerard,Paul E. Aldrich,Richard Stalin Bautista Guzmán,Xiaoshu Gao,Patrick Y. S. Lam	1994	15
7	Studies on Orally Available Inhibitors of HIV Protease. Peptidyl Aldehydes and Trifluoromethyl Ketones Antiviral chemistry & chemotherapy ·C. Nicholas Hodge,Paul E. Aldrich,Cấnh Toàn Nguyễn,Eun Young Park,Marlene M. Rayner,Y. Nancy Wong,Susan Erickson‐Viitanen	1994	8
8	Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic. Journal of Pharmacology and Experimental Therapeutics ·Pancras C. Wong,Paul E. Aldrich,Andrew T. Chiu,Richard A. Earl,Абдиев К. Ж.,A.L. Johnson,Phillip Ma,Dale E. McCall,William A. Price,John R. Carey	1993	2
9	In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease. Proceedings of the National Academy of Sciences ·Eun Young Park,Sena Garber,Dean L. Winslow,Carol Reid,Paul E. Aldrich,Kent Manning,Catherine E. Patterson,C. Nicholas Hodge,Y S Cheng	1993	114
10	ChemInform Abstract: Nonpeptide Angiotensin II Receptor Antagonists: The Discovery of a Series of N‐(Biphenylylmethyl)imidazoles as Potent, Orally Active Antihypertensives. ChemInform ·David J. Carini,John V. Duncia,Paul E. Aldrich,Andrew T. Chiu,A.L. Johnson,Michael E. Pierce,William A. Price,Joseph B. Santella,Gregory J. Wells,Ruth R. Wexler,Pancras C. Wong,Sung‐Eun Yoo,Pieter B.M.W.M. Timmermans	1991	1
11	Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensivesbreakdown → Journal of Medicinal Chemistry ·David J. Carini,John V. Duncia,Paul E. Aldrich,Andrew T. Chiu,A.L. Johnson,Michael E. Pierce,William A. Price,Joseph B. Santella,Gregory J. Wells	1991	369
12	[3H]DuP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype Biochemical and Biophysical Research Communications ·Andrew T. Chiu,Dale E. McCall,Paul E. Aldrich,Pieter B.M.W.M. Timmermans	1990	66
13	An Integrated Model of Management and Managerial Development Journal of Management Development ·Laurie J. Mullins,Paul E. Aldrich	1988	7
14	Total synthesis of yohimbine Journal of the American Chemical Society ·Eugene E. Van Tamelen,Maurice Shamma,Albert W. Burgstahler,Joseph Wolinsky,絵里亀井,Paul E. Aldrich	1969	32
15	The Stereochemistry of Reserpine, Deserpidine and Related Alkaloids^1,2 Journal of the American Chemical Society ·Paul E. Aldrich,Martin Gätzi,Alain Chambert,Ragheb Salim,میرسعید سید دراجی,Charles F. Huebner,Ni Made Cintya Dwi Apsari,D Basavesha,D.O. Perkins,H. B. MacPhillamy,Ernest W. Robb,Anastasiia Leonteva,E. Schlittler,Сергей Владимирович Гувернюк,Eugene E. Van Tamelen,Frank L. Weisenborn,Ernest Wenkert,O. Wintersteiner	1959	16
16	THE TOTAL SYNTHESIS OF YOHIMBINE Journal of the American Chemical Society ·尚子成沢,Maurice Shamma,Albert W. Burgstahler,Joseph Wolinsky,絵里亀井,Paul E. Aldrich	1958	39
17	Stereochemistry of Corynantheine, Dihydrocorynantheine and Corynantheidine¹ Journal of the American Chemical Society ·Vyacheslav Soloviev,Paul E. Aldrich,Thomas J. Katz	1957	13
18	Determination of Structure of β,δ-Dihydroxy-β-methylvaleric Acid Journal of the American Chemical Society ·Donald E. Wolf,Carl H. Hoffman,Paul E. Aldrich,Helen R. Skeggs,Lemuel D. Wright,Karl Folkers	1957	30
19	β-HYDROXY-β-METHYL-δ-VALEROLACTONE (DIVALONIC ACID), A NEW BIOLOGICAL FACTOR Journal of the American Chemical Society ·Donald E. Wolf,Carl H. Hoffman,Paul E. Aldrich,Helen R. Skeggs,Lemuel D. Wright,Karl Folkers	1956	62
20	The Stereospecific Synthesis of dl-Yohimbane. Stereochemistry of Yohimbine¹ Journal of the American Chemical Society ·Eugene E. Van Tamelen,Maurice Shamma,Paul E. Aldrich	1956	16

About Paul E. Aldrich

Paul E. Aldrich is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers), Chemical synthesis and alkaloids (4 papers), Botanical Research and Chemistry (3 papers), HIV/AIDS Research and Interventions (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Obsessive-Compulsive Spectrum Disorders (2 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Virology (206 citations), Organic Chemistry (532 citations) and Infectious Diseases (240 citations). Paul E. Aldrich has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Andrew T. Chiu, Michael E. Pierce, William A. Price, Joseph B. Santella, David J. Carini, A.L. Johnson, John V. Duncia, Gregory J. Wells, Eugene E. Van Tamelen and C. Nicholas Hodge. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, Journal of Management Development and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact